Multiple genetic risk variants for various AID, including MS, have been identified, impacting immune function [35] and potentially leading to accelerated immune aging, malfunction of immune effector cells, and irreversible tissue damage [39]. The gene discussed is AICDA; the disease is myeloid sarcoma.